longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

HITECK

300683

23.942.09% ( -0.51 )
Delay Midday Break: Sep 10, 11:29:57
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI
  • Innovative drug concept stocks rapidly plummeted, with NEPTUNUS hitting the daily limit, RemeGen falling more than 10%, and many stocks including Cosunter, Rundu Pharma, Sunshine Guojian Pharmaceutical, SL PHARM, and HITECK dropping more than 6%

    Wallstreetcn·Apr 7 at 01:41 AM
    512290-1.08%002038-2.54%
  • Shanghai Composite Index Volatile Up, Innovative Drugs and Auto Stocks Rally Mid-day, Commercial Aerospace Active, Hang Seng Tech Index Surges and Falls Back, Tech Stocks Diverge

    Wallstreetcn·Mar 31 at 08:37 AM
    - On March 31, A-shares experienced fluctuations, with the Shanghai index rising by 0.45%, while the ChiNext index fell by 0.41%. - Hong Kong stocks opened strong but narrowed their gains, with the Hang Seng index up 0.15%. - The bond market showed mixed results, and commodity futures mostly declined, although metals like silver and gold increased.
    002821-1.47%002361+2.57%
  • The A-share innovative drug concept fluctuated and declined, with SDKX falling over 10%. INNOSTAR, HITECK, Aidea Pharma, Chemexpress, and Beilu Pharma had significant declines

    Wallstreetcn·Mar 19 at 06:30 AM
    300016-4.42%688136-3.28%
  • The three major A-share indices collectively fell at the midday break, with the electrical engineering and power grid sector leading the decline

    36Kr·Nov 17, 2025 at 03:36 AM
    300683-2.09%000603-1.27%
  • HITECK released its performance for the first three quarters, with a net loss attributable to the parent company of 158 million yuan

    Zhitong·Oct 22, 2025 at 12:54 PM
    300683-2.09%
  • Innovative drug concept stocks continue to be active, HUAPONT LIFE SCIENCES hits the limit up

    Zhitong·Oct 17, 2025 at 01:44 AM
    300683-2.09%002004+0.87%
  • HITECK released its performance for the first half of the year, with a net loss attributable to the parent company of 39.1799 million yuan, an increase of 72.10%

    Zhitong·Aug 25, 2025 at 04:18 PM
    300683-2.09%
  • The innovative drug sector surged in the short term, with Chimin hitting the daily limit

    Zhitong·Aug 19, 2025 at 01:32 AM
    603222-1.35%002873-1.41%
  • The concept of innovative drugs has strengthened again, with Hotgen rising over 10% to reach a new historical high

    Zhitong·Aug 6, 2025 at 01:39 AM
    002773-1.40%688068-3.11%
  • CRO concept stocks fluctuated lower in early trading, Ausun Pharm fell over 8%

    Zhitong·Aug 4, 2025 at 01:44 AM
    603127-2.65%06127-3.80%
  • CRO/CMO concept experiences a volatile surge, ChemPartner hits the "20cm" limit up

    Zhitong·Jul 29, 2025 at 05:34 AM
    603456-3.13%300347-0.69%
  • The pharmaceutical sector fluctuates and strengthens, with multiple stocks hitting the daily limit

    Zhitong·Jul 29, 2025 at 02:35 AM
    300725-3.36%002370-3.77%
  • The cell immunotherapy sector is partially active, with Sanyuan Gene rising over 12%

    Zhitong·Jul 29, 2025 at 02:06 AM
    688621+1.61%603127-2.65%
  • The A-share innovative drug concept continues to be strong, with YABAO PHARM.CORP hitting the limit up, and JENKEM, HSGC, YKYY, MEDISAN, HITECK, and others leading in gains

    Wallstreetcn·Jul 24, 2025 at 01:32 AM
    600351-2.32%688356-4.14%
  • The concept of innovative drugs fluctuates and rebounds, HITECK and ClinPlus rise over 10%

    Zhitong·Jul 23, 2025 at 02:04 AM
    301257-4.83%300683-2.09%